HIV/AIDS
Data on HIV/AIDS described by G. Skowron et al
Published in AIDS Weekly, April 20th, 2009
In this recent report, researchers in the United States conducted a study "To evaluate the association between baseline (BL) replication capacity (RC) (RCBL) and immunologic/virologic parameters (at BL and after 48 weeks on therapy) in HIV-1-infected subjects initiating antiretroviral therapy. RCBL was determined using a modified Monogram PhenoSense HIV drug susceptibility assay on plasma HIV-1 from 321 treatment-naive subjects from AIDS Clinical Trials Group 384."
"Univariate and multivariable analyses were performed to determine the association of RCBL with BL and on-therapy virologic and immunologic outcomes. Higher RCBL, was associated with lower baseline CD4...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-04-20)
More Articles from AIDS Weekly
- University of Washington - Health Sciences/UW News, Community Relations & Marketing
More compelling evidence on why earlier HIV treatment lengthens survival - Antifungals
Research conducted at United Arab Emirates University has updated our knowledge about antifungals - HIV/AIDS
Data on HIV/AIDS discussed by researchers at Kyoto University - HIV/AIDS
Findings in HIV/AIDS reported from J.S. Lafuente and co-researchers - HIV/AIDS
New HIV/AIDS study findings have been reported by researchers at Cornell University - HIV/AIDS
New HIV/AIDS study findings have been reported from F. Hoffmann-LaRoche Ltd. - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
